Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 17.07 CNY 0.41% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

Shijiazhuang Yiling Pharmaceutical Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shijiazhuang Yiling Pharmaceutical Co Ltd
Total Equity Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Total Equity
ÂĄ11.5B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
10%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Equity
ÂĄ25.8B
CAGR 3-Years
13%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Equity
ÂĄ13.7B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Equity
ÂĄ42.6B
CAGR 3-Years
9%
CAGR 5-Years
14%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Equity
ÂĄ39.4B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Equity
ÂĄ151.9m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Total Equity?
Total Equity
11.5B CNY

Based on the financial report for Jun 30, 2024, Shijiazhuang Yiling Pharmaceutical Co Ltd's Total Equity amounts to 11.5B CNY.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
10%

Over the last year, the Total Equity growth was -2%. The average annual Total Equity growth rates for Shijiazhuang Yiling Pharmaceutical Co Ltd have been 10% over the past three years , 8% over the past five years , and 10% over the past ten years .

Back to Top